Better or Worse? The Independent Prognostic Role of HPV-16 or HPV-18 Positivity in Patients With Cervical Cancer: A Meta-Analysis and Systematic Review

Background: The literature reports conflicting results regarding the effect of human papillomavirus (HPV) genotype 16 (HPV-16)/18 (HPV-18) positivity on cervical cancer (CC) prognosis.Aim: To conduct a meta-analysis to examine the effect of HPV-16/18 positivity on the prognosis of patients with CC.M...

Full description

Bibliographic Details
Main Authors: Xing Chen, Ping Zhang, Shanshan Chen, Hanxiao Zhu, Kai Wang, Liya Ye, Jun Wang, Junhui Yu, Shuangshuang Mei, Zhengrong Wang, Xiaodong Cheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.01733/full
id doaj-318f35ce5d41479eb83b61834b745c8c
record_format Article
spelling doaj-318f35ce5d41479eb83b61834b745c8c2020-11-25T03:05:19ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2020-10-011010.3389/fonc.2020.01733557475Better or Worse? The Independent Prognostic Role of HPV-16 or HPV-18 Positivity in Patients With Cervical Cancer: A Meta-Analysis and Systematic ReviewXing Chen0Ping Zhang1Shanshan Chen2Hanxiao Zhu3Kai Wang4Liya Ye5Jun Wang6Junhui Yu7Shuangshuang Mei8Zhengrong Wang9Xiaodong Cheng10Zhejiang Taizhou Hospital, Taizhou, ChinaZhejiang Cancer Hospital, University of Chinese Academy of Sciences, Hangzhou, ChinaZhejiang Taizhou Hospital, Taizhou, ChinaZhejiang Taizhou Hospital, Taizhou, ChinaZhejiang Taizhou Hospital, Taizhou, ChinaZhejiang Taizhou Hospital, Taizhou, ChinaZhejiang Taizhou Hospital, Taizhou, ChinaZhejiang Taizhou Hospital, Taizhou, ChinaZhejiang Taizhou Hospital, Taizhou, ChinaZhejiang Taizhou Hospital, Taizhou, ChinaWomen's Hospital, School of Medicine, Zhejiang University, Hangzhou, ChinaBackground: The literature reports conflicting results regarding the effect of human papillomavirus (HPV) genotype 16 (HPV-16)/18 (HPV-18) positivity on cervical cancer (CC) prognosis.Aim: To conduct a meta-analysis to examine the effect of HPV-16/18 positivity on the prognosis of patients with CC.Methods: PubMed, Embase, and the Cochrane Library were searched for available papers published up to March 2020. The main outcome was the hazard ratio (HR) of overall survival (OS) or disease-free survival (DFS) comparing HPV-16 or HPV-18 positivity and negativity. The random-effects model was used for synthesizing survival outcomes.Results: Nine studies and 2,028 patients were included. Four studies reported OS in HPV-16 positivity, and no association was found between HPV-16 positivity and OS to CC (HR = 0.79, 95% CI: 0.26–2.39, P = 0.675). Three studies reported DFS in HPV-16 positivity, and no association was found between HPV-16 positivity and DFS to CC (HR = 0.80, 95% CI: 0.30–2.11, P = 0.654). Two studies reported DFS in HPV-18 positivity, and no association was found between HPV-18 positivity and DFS to CC (HR = 0.99, 95% CI: 0.55–1.78, P = 0.984). One study reported progression-free survival (PFS) in HPV-18 positivity, and an association was observed between HPV-18 positivity and PFS to CC (HR = 2.66, 95% CI: 1.44–4.94, P = 0.002). The sensitivity analyses showed that one study biased the analysis of the association between HPV-16 and OS, and another study biased the association between HPV-16 and DFS.Conclusion: The presence of HPV-16 and HPV-18 positivity appears to have no significant association with prognosis in CC in either OS or PFS. The presence of HPV-16 or HPV-18 positivity has no significant association with prognosis in CC in either OS or PFS.https://www.frontiersin.org/article/10.3389/fonc.2020.01733/fullhuman papillomavirus 16human papillomavirus 18uterine cervical neoplasmsprognosismeta-analysis
collection DOAJ
language English
format Article
sources DOAJ
author Xing Chen
Ping Zhang
Shanshan Chen
Hanxiao Zhu
Kai Wang
Liya Ye
Jun Wang
Junhui Yu
Shuangshuang Mei
Zhengrong Wang
Xiaodong Cheng
spellingShingle Xing Chen
Ping Zhang
Shanshan Chen
Hanxiao Zhu
Kai Wang
Liya Ye
Jun Wang
Junhui Yu
Shuangshuang Mei
Zhengrong Wang
Xiaodong Cheng
Better or Worse? The Independent Prognostic Role of HPV-16 or HPV-18 Positivity in Patients With Cervical Cancer: A Meta-Analysis and Systematic Review
Frontiers in Oncology
human papillomavirus 16
human papillomavirus 18
uterine cervical neoplasms
prognosis
meta-analysis
author_facet Xing Chen
Ping Zhang
Shanshan Chen
Hanxiao Zhu
Kai Wang
Liya Ye
Jun Wang
Junhui Yu
Shuangshuang Mei
Zhengrong Wang
Xiaodong Cheng
author_sort Xing Chen
title Better or Worse? The Independent Prognostic Role of HPV-16 or HPV-18 Positivity in Patients With Cervical Cancer: A Meta-Analysis and Systematic Review
title_short Better or Worse? The Independent Prognostic Role of HPV-16 or HPV-18 Positivity in Patients With Cervical Cancer: A Meta-Analysis and Systematic Review
title_full Better or Worse? The Independent Prognostic Role of HPV-16 or HPV-18 Positivity in Patients With Cervical Cancer: A Meta-Analysis and Systematic Review
title_fullStr Better or Worse? The Independent Prognostic Role of HPV-16 or HPV-18 Positivity in Patients With Cervical Cancer: A Meta-Analysis and Systematic Review
title_full_unstemmed Better or Worse? The Independent Prognostic Role of HPV-16 or HPV-18 Positivity in Patients With Cervical Cancer: A Meta-Analysis and Systematic Review
title_sort better or worse? the independent prognostic role of hpv-16 or hpv-18 positivity in patients with cervical cancer: a meta-analysis and systematic review
publisher Frontiers Media S.A.
series Frontiers in Oncology
issn 2234-943X
publishDate 2020-10-01
description Background: The literature reports conflicting results regarding the effect of human papillomavirus (HPV) genotype 16 (HPV-16)/18 (HPV-18) positivity on cervical cancer (CC) prognosis.Aim: To conduct a meta-analysis to examine the effect of HPV-16/18 positivity on the prognosis of patients with CC.Methods: PubMed, Embase, and the Cochrane Library were searched for available papers published up to March 2020. The main outcome was the hazard ratio (HR) of overall survival (OS) or disease-free survival (DFS) comparing HPV-16 or HPV-18 positivity and negativity. The random-effects model was used for synthesizing survival outcomes.Results: Nine studies and 2,028 patients were included. Four studies reported OS in HPV-16 positivity, and no association was found between HPV-16 positivity and OS to CC (HR = 0.79, 95% CI: 0.26–2.39, P = 0.675). Three studies reported DFS in HPV-16 positivity, and no association was found between HPV-16 positivity and DFS to CC (HR = 0.80, 95% CI: 0.30–2.11, P = 0.654). Two studies reported DFS in HPV-18 positivity, and no association was found between HPV-18 positivity and DFS to CC (HR = 0.99, 95% CI: 0.55–1.78, P = 0.984). One study reported progression-free survival (PFS) in HPV-18 positivity, and an association was observed between HPV-18 positivity and PFS to CC (HR = 2.66, 95% CI: 1.44–4.94, P = 0.002). The sensitivity analyses showed that one study biased the analysis of the association between HPV-16 and OS, and another study biased the association between HPV-16 and DFS.Conclusion: The presence of HPV-16 and HPV-18 positivity appears to have no significant association with prognosis in CC in either OS or PFS. The presence of HPV-16 or HPV-18 positivity has no significant association with prognosis in CC in either OS or PFS.
topic human papillomavirus 16
human papillomavirus 18
uterine cervical neoplasms
prognosis
meta-analysis
url https://www.frontiersin.org/article/10.3389/fonc.2020.01733/full
work_keys_str_mv AT xingchen betterorworsetheindependentprognosticroleofhpv16orhpv18positivityinpatientswithcervicalcancerametaanalysisandsystematicreview
AT pingzhang betterorworsetheindependentprognosticroleofhpv16orhpv18positivityinpatientswithcervicalcancerametaanalysisandsystematicreview
AT shanshanchen betterorworsetheindependentprognosticroleofhpv16orhpv18positivityinpatientswithcervicalcancerametaanalysisandsystematicreview
AT hanxiaozhu betterorworsetheindependentprognosticroleofhpv16orhpv18positivityinpatientswithcervicalcancerametaanalysisandsystematicreview
AT kaiwang betterorworsetheindependentprognosticroleofhpv16orhpv18positivityinpatientswithcervicalcancerametaanalysisandsystematicreview
AT liyaye betterorworsetheindependentprognosticroleofhpv16orhpv18positivityinpatientswithcervicalcancerametaanalysisandsystematicreview
AT junwang betterorworsetheindependentprognosticroleofhpv16orhpv18positivityinpatientswithcervicalcancerametaanalysisandsystematicreview
AT junhuiyu betterorworsetheindependentprognosticroleofhpv16orhpv18positivityinpatientswithcervicalcancerametaanalysisandsystematicreview
AT shuangshuangmei betterorworsetheindependentprognosticroleofhpv16orhpv18positivityinpatientswithcervicalcancerametaanalysisandsystematicreview
AT zhengrongwang betterorworsetheindependentprognosticroleofhpv16orhpv18positivityinpatientswithcervicalcancerametaanalysisandsystematicreview
AT xiaodongcheng betterorworsetheindependentprognosticroleofhpv16orhpv18positivityinpatientswithcervicalcancerametaanalysisandsystematicreview
_version_ 1724679158182707200